Moderna, Inc. (LON:0A45)
London · Delayed Price · Currency is GBP · Price in USD 30.03
+0.60 (2.04%)
At close: Dec 12, 2025
Moderna Market Cap
Moderna has a market cap or net worth of 8.62 billion as of December 12, 2025. Its market cap has decreased by -33.17% in one year.
Market Cap
8.62B
Enterprise Value
4.19B
Revenue
1.66B
Ranking
n/a
PE Ratio
n/a
Stock Price
30.03
Market Cap Chart
Since December 7, 2018, Moderna's market cap has increased from 4.80B to 8.62B, an increase of 79.52%. That is a compound annual growth rate of 8.69%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 12, 2025 | 8.62B | -32.57% |
| Dec 31, 2024 | 12.78B | -57.07% |
| Dec 29, 2023 | 29.77B | -48.02% |
| Dec 30, 2022 | 57.27B | -24.69% |
| Dec 31, 2021 | 76.05B | 151.16% |
| Dec 31, 2020 | 30.28B | 515.21% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 7, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 210.84B |
| HSBC Holdings | 190.77B |
| Shell | 155.38B |
| Unilever | 107.41B |
| Rio Tinto Group | 97.08B |
| British American Tobacco p.l.c. | 95.33B |
| Rolls-Royce Holdings | 92.08B |
| GSK plc | 73.12B |